Stand Up To Cancer, St. Baldrick’s Foundation Hail Green Light for CAR T Cell Therapy for Leukemia – PR Newswire (press release)
|
Stand Up To Cancer, St. Baldrick’s Foundation Hail Green Light for CAR T Cell Therapy for Leukemia
PR Newswire (press release) SU2C and the St. Baldrick’s Foundation, the largest private funder of childhood cancer research grants, have committed millions of dollars to the development of the chimeric antigen receptor (CAR) T cell therapy, especially investigating why some … |
Nature.com |
Engineered cell therapy for cancer gets thumbs up from FDA advisers
Nature.com This is in stark contrast to some other CAR-T trials that have, over the past year, reported the death of several patients from severe brain swelling. Novartis’ therapy is not identical to the CAR–T cells used in those trials, which were administered … |
|
FDA advisers endorse what could be 1st US gene therapy
WEAR CAR-T therapy starts with filtering key immune cells called T cells from a patient’s blood. In a lab, a gene is then inserted into the T cells that prompts them to grow a receptor that targets a special marker found on some blood cancers. Millions of … |
